Hin Au

Hin Au

Associate

Patents and Innovations

Hin Au is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Hin provides IP strategy and counseling services to clients in a wide range of technical fields, including MedTech, digital health, biotech, medical/diagnostic devices, software, robotics, autonomous vehicle technologies, and clean energy. He has assisted many clients with building their patent portfolios and securing key strategic patents. Hin has hands-on engineering industry experience, having previously worked as an R&D engineer for six years at large U.S. semiconductor corporations. A native of Singapore, Hin is also fluent in Mandarin and Cantonese.

Experience

Education

J.D., Santa Clara University School of Law
M.S., Mechanical Engineering, Massachusetts Institute of Technology
B.S., Mechanical Engineering, University of Michigan, Ann Arbor

Admissions

State Bar of California
U.S. District Court for the Northern District of California
U.S. Patent and Trademark Office

Credentials

Education

J.D., Santa Clara University School of Law
M.S., Mechanical Engineering, Massachusetts Institute of Technology
B.S., Mechanical Engineering, University of Michigan, Ann Arbor

Admissions

State Bar of California
U.S. District Court for the Northern District of California
U.S. Patent and Trademark Office

Recent Insights

Client Highlights

On October 1, 2024, Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announced the acquisition of all the assets of Dimien Inc., a private U.S. vanadium cathode materials company. Pure Lithium acquired Dimien’s intellectual property, know-how, and manufacturing equipment. Dimien's experienced team will also join the company. Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction.

Learn More

Newsletters

This latest edition features articles on biotech client Siolta Therapeutics, the use of safety and efficacy findings to extend drug exclusivity periods, life sciences venture financings for clients in 2023, and updated USPTO guidance for determining non-obviousness. The newsletter also includes details on the recent LaunchBio NextGen VC Forum in San Francisco, the firm’s Patents and Innovations Learning Library for in-house IP counsel, the latest episodes of the LaunchBio/Wilson Sonsini NextGen VC Podcast focused on life sciences investing, and the firm’s sponsorship of the National Inventors Hall of Fame Induction Ceremony, as well as select life sciences client highlights.

Learn More

View All

Recent Events

WSGR Events

Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.

Learn More

WSGR Events

Wilson Sonsini is pleased to present the Innovator’s Edge Series. Life sciences companies should be aware of the relevant intellectual property rights of competitors and other third parties, as infringement of such rights could lead to undesired outcomes, such as unwanted litigation, significant monetary payouts, or even shutdown of the company. This webinar will present important steps that can be taken to identify and reduce risks that arise from the patent rights of others.

Learn More